Frizzled2 (FZD2) is a receptor for Wnts and may activate both canonical and non-canonical Wnt signaling pathways in cancer. However, no studies have reported an association between FZD2 signaling and high-risk NB so far. Here we report that FZD2 signaling pathways are critical to NB growth in MYCN-single copy SK-N-AS and MYCN-amplified SK-N-DZ high-risk NB cells. We demonstrate that stimulation of FZD2 by Wnt3a and Wnt5a regulates β-catenin-dependent and -independent Wnt signaling factors. FZD2 blockade suppressed β-catenin-dependent signaling activity and increased phosphorylation of PKC, AKT and ERK in vitro, consistent with upregulation of β-catenin-independent signaling activity. Finally, FZD2 small interfering RNA knockdown suppressed tumor growth in murine NB xenograft models associated with suppressed β-catenin-dependent signaling and a less vascularized phenotype in both NB xenografts. Together, our study suggests a role for FZD2 in high-risk NB cell growth and provides a potential candidate for therapeutic inhibition in FZD2-expressing NB patients.
CITATION STYLE
Zins, K., Schäfer, R., Paulus, P., Dobler, S., Fakhari, N., Sioud, M., … Abraham, D. (2016). Frizzled2 signaling regulates growth of high-risk neuroblastomas by interfering with β-catenin-dependent and β-cateninindependent signaling pathways. Oncotarget, 7(29), 46187–46202. https://doi.org/10.18632/oncotarget.10070
Mendeley helps you to discover research relevant for your work.